Search Result "Systemic Intraperitoneal (IP)"
Intraperitoneal Drug Therapy: An Advantage
Journal: Current Clinical Pharmacology
Volume: 5 Issue: 2 Year: 2010 Page: 82-88
Author(s): Kunal Chaudhary, Shadi Haddadin, Ravi Nistala, Chris Papageorgio
Synergetic Bitherapy in Mice with Xenografts of Human Prostate Cancer Using a Methional Mimic (METLICO) and an Aldehyde Dehydrogenase 3 Inhibitor (MATE): Systemic Intraperitoneal (IP) and Targeted Intra-Tumoral (IT) Administration
Journal: Current Medicinal Chemistry
Volume: 16 Issue: 1 Year: 2009 Page: 1184-1191
Author(s): E. Hiltbrand, G. Fournet, J-P. Giliberto, M-J. Paret, J. Chantepie, D. Morel, J. Gore, U. Reichert, H. Mehier, M-E. Rochedix, G. Quash
Intraperitoneal Chemotherapy as First-Line Treatment in the Management of Epithelial Ovarian Cancer
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 7 Issue: 5 Year: 2007 Page: 511-519
Author(s): S. Rekhraj, J. Kinross, S. Prabhudesai, A. Darzi, P. Ziprin
Intraperitoneal Chemotherapy as Primary Treatment of Advanced Ovarian Cancer:Efficacy, Toxicity, and Future Directions
Journal: Reviews on Recent Clinical Trials
Volume: 2 Issue: 3 Year: 2007 Page: 169-173
Author(s): Maurie Markman
Delivery Efficacy Differences of Intravenous and Intraperitoneal Injection of Exosomes: Perspectives from Tracking Dye Labeled and MiRNA Encapsulated Exosomes
Journal: Current Drug Delivery
Volume: 17 Issue: 3 Year: 2020 Page: 186-194
Author(s): Xueying Zhou,Zhelong Li,Wenqi Sun,Guodong Yang,Changyang Xing,Lijun Yuan
Nanofibrous Polydioxanone Depots for Prolonged Intraperitoneal Paclitaxel Delivery
Journal: Current Drug Delivery
Volume: 16 Issue: 7 Year: 2019 Page: 654-662
Author(s): Smrithi Padmakumar,Deepthy Menon
Radioprotective Effects of Amifostine, L-Carnitine and Vitamin E in Preventing Early Salivary Gland Injury due to Radioactive Iodine Treatment
Journal: Current Medical Imaging
Volume: 15 Issue: 4 Year: 2019 Page: 395-404
Author(s): Nese Torun,Asli Muratli,Burcu Dirlik Serim,Alev Ergulen,Gulay Durmus Altun
Targeting the Chemokine Receptor CXCR3 and Its Ligand CXCL10 in the Central Nervous System: Potential Therapy for Inflammatory Demyelinating Disease?
Journal: Current Neurovascular Research
Volume: 1 Issue: 2 Year: 2004 Page: 183-190
Author(s):
Using Pharmacologic Data to Plan Clinical Treatments for Patients with Peritoneal Surface Malignancy
Journal: Current Drug Discovery Technologies
Volume: 6 Issue: 1 Year: 2009 Page: 72-81
Author(s): Kurt Van der Speeten, Oswald Anthony Stuart, Paul H. Sugarbaker
Identification of a Therapeutic Dose of Continuously Delivered Erythropoietin in the Eye Using An Inducible Promoter System
Journal: Current Gene Therapy
Volume: 13 Issue: 4 Year: 2013 Page: 275-281
Author(s): Jessica Hines—Beard,Siddharth Desai,Rachel Haag,Noriko Esumi,Lauren D’Surney,Scott Parker,Cody Richardson,Tonia S. Rex